CCN2 and pancreatic neoplasm: Pancreatic cancer, TME, contains various possible therapy targets, such as HA, focal adhesion kinase (FAK), connective tissue growth factor (CTGF), CD40, and chemokine (C-X-C motif) receptor 4 (CXCR-4), which could be utilized in future clinical applications [260].